COVID-19 comorbidities, associated procoagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity?
作者信息
Inal Jameel
机构信息
School of Human Sciences, London Metropolitan University, London, UK.
School of Life and Medical Sciences, University of Hertfordshire, Hertfordshire, UK.
出版信息
Br J Haematol. 2020 Aug;190(4):e218-e220. doi: 10.1111/bjh.17011. Epub 2020 Jul 30.
Abstract
摘要
相似文献
1
COVID-19 comorbidities, associated procoagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity?2019冠状病毒病合并症、相关促凝血细胞外囊泡与静脉血栓栓塞：与种族是否存在潜在联系？
Br J Haematol. 2020 Aug;190(4):e218-e220. doi: 10.1111/bjh.17011. Epub 2020 Jul 30.
2
ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study.ABO血型、新型冠状病毒2019感染与静脉血栓栓塞风险：基于人群的队列研究
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211008986. doi: 10.1177/10760296211008986.
3
Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.D-二聚体在预测非机械通气的新冠病毒疾病幸存者静脉血栓栓塞中的应用
Thromb Res. 2021 Mar;199:82-84. doi: 10.1016/j.thromres.2020.12.023. Epub 2020 Dec 26.
4
The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19.抗血小板药物在新型冠状病毒肺炎动脉血栓预防中的应用。
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):114-115. doi: 10.1016/j.rec.2020.08.009. Epub 2020 Aug 28.
5
Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection.循环细胞外囊泡在 SARS-CoV-2 感染中具有增强的促凝活性。
EBioMedicine. 2021 May;67:103369. doi: 10.1016/j.ebiom.2021.103369. Epub 2021 May 7.
6
Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly.硫酸乙酰肝素和乙酰肝素酶与老年人 COVID-19 严重程度的相关性
Semin Thromb Hemost. 2021 Jun;47(4):348-350. doi: 10.1055/s-0040-1722293. Epub 2021 Jan 11.
7
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report.新冠病毒病患者循环细胞外囊泡组织因子活性水平升高，且与疾病严重程度和死亡率相关——简要报告
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):878-882. doi: 10.1161/ATVBAHA.120.315547. Epub 2020 Dec 3.
8
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization.COVID-19 住院后出院患者的静脉血栓栓塞症。
Semin Thromb Hemost. 2021 Jun;47(4):362-371. doi: 10.1055/s-0041-1727284. Epub 2021 Apr 23.
9
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.新冠肺炎癌症患者的血栓形成与止血问题
Semin Thromb Hemost. 2020 Oct;46(7):785-788. doi: 10.1055/s-0040-1714275. Epub 2020 Aug 12.
10
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.新型冠状病毒2型感染与手术后静脉血栓栓塞：一项国际前瞻性队列研究。
Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. Epub 2021 Aug 24.
引用本文的文献
1
Rescuing fertility during COVID-19 infection: exploring potential pharmacological and natural therapeutic approaches for comorbidity, by focusing on NLRP3 inflammasome mechanism.在 COVID-19 感染期间拯救生育能力：通过关注 NLRP3 炎症小体机制，探索潜在的治疗合并症的药理学和自然治疗方法。
J Assist Reprod Genet. 2023 May;40(5):1173-1185. doi: 10.1007/s10815-023-02768-1. Epub 2023 Mar 9.
2
Therapeutic use of calpeptin in COVID-19 infection.Calpeptin 在 COVID-19 感染中的治疗用途。
Clin Sci (Lond). 2022 Oct 28;136(20):1439-1447. doi: 10.1042/CS20220638.
3
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.新型冠状病毒肺炎血栓形成风险的当前和新型生物标志物：国际新型冠状病毒肺炎血栓形成生物标志物座谈会共识声明。
Nat Rev Cardiol. 2022 Jul;19(7):475-495. doi: 10.1038/s41569-021-00665-7. Epub 2022 Jan 13.
4
The Role of Extracellular Vesicles as a Shared Disease Mechanism Contributing to Multimorbidity in Patients With COPD.细胞外囊泡作为一种共同的疾病机制，在 COPD 患者的多病共存中发挥作用。
Front Immunol. 2021 Dec 2;12:754004. doi: 10.3389/fimmu.2021.754004. eCollection 2021.
5
Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence.细胞外囊泡与血栓形成：临床与实验研究进展。
Int J Mol Sci. 2021 Aug 27;22(17):9317. doi: 10.3390/ijms22179317.
6
The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge.细胞外囊泡在新冠病毒病治疗中的潜在作用：机遇与挑战
Front Mol Biosci. 2021 Jul 21;8:699929. doi: 10.3389/fmolb.2021.699929. eCollection 2021.
7
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles.2019冠状病毒病与血栓形成的生物标志物：聚焦于血管性血友病因子和细胞外囊泡
J Thromb Thrombolysis. 2021 Nov;52(4):1010-1019. doi: 10.1007/s11239-021-02544-x. Epub 2021 Aug 4.
8
Machining learning predicts the need for escalated care and mortality in COVID-19 patients from clinical variables.机器学习通过临床变量预测 COVID-19 患者需要升级护理和死亡的情况。
Int J Med Sci. 2021 Feb 18;18(8):1739-1745. doi: 10.7150/ijms.51235. eCollection 2021.
9
Extracellular Vesicles: Roles in Human Viral Infections, Immune-Diagnostic, and Therapeutic Applications.细胞外囊泡：在人类病毒感染、免疫诊断及治疗应用中的作用
Pathogens. 2020 Dec 17;9(12):1056. doi: 10.3390/pathogens9121056.
10
Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?细胞外囊泡在病毒感染中的作用：同一枚硬币的两面？
Front Cell Infect Microbiol. 2020 Dec 1;10:593170. doi: 10.3389/fcimb.2020.593170. eCollection 2020.
本文引用的文献
1
Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data.英格兰的黑人、亚裔和少数族裔群体死于新冠病毒的风险更高：英国国家医疗服务体系（NHS）死亡率数据的间接标准化
Wellcome Open Res. 2020 Jun 24;5:88. doi: 10.12688/wellcomeopenres.15922.2. eCollection 2020.
2
Black-White Risk Differentials in COVID-19 (SARS-COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges.美国 COVID-19（SARS-COV2）传播、死亡率和病死率的黑-白风险差异：转化流行病学视角和挑战。
Int J Environ Res Public Health. 2020 Jun 17;17(12):4322. doi: 10.3390/ijerph17124322.
3
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.血管内皮：严重 SARS-CoV-2 感染导致器官功能障碍的基石。
Crit Care. 2020 Jun 16;24(1):353. doi: 10.1186/s13054-020-03062-7.
4
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高：更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
5
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.严重 COVID-19 感染发病机制中的补体相关微血管损伤和血栓形成：五例报告。
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
6
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响：系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
7
Association of Extracellular Vesicle Protein Cargo with Race and Clinical Markers of Mortality.细胞外囊泡蛋白载物与种族和死亡临床标志物的关联。
Sci Rep. 2019 Nov 26;9(1):17582. doi: 10.1038/s41598-019-53640-1.
8
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis.细胞外囊泡（EVs）在血栓形成发病机制中的生物学作用和角色。
Int J Mol Sci. 2019 Jun 11;20(11):2840. doi: 10.3390/ijms20112840.
9
Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes.糖尿病中外泌体浓度、内容物和功能的改变。
Diabetes. 2018 Nov;67(11):2377-2388. doi: 10.2337/db17-1308. Epub 2018 May 2.
10
Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.弗明汉心脏研究中循环内皮微粒与心血管代谢危险因素的关联
Eur Heart J. 2014 Nov 7;35(42):2972-9. doi: 10.1093/eurheartj/ehu153. Epub 2014 Apr 16.
Zotero 插件